SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation. [electronic resource]
Producer: 20030724Description: 407-20 p. digitalISSN:- 0022-3565
- Animals
- Azepines -- therapeutic use
- Behavior, Animal -- drug effects
- Body Temperature -- drug effects
- Brain -- metabolism
- Cardiovascular System -- drug effects
- Cells, Cultured
- Dextroamphetamine -- pharmacology
- Discrimination Learning
- Drug Interactions
- Heterocyclic Compounds, 4 or More Rings -- therapeutic use
- Humans
- Male
- Mecamylamine -- pharmacology
- Microdialysis
- Motor Activity -- drug effects
- Nicotine -- pharmacology
- Nicotinic Agonists -- therapeutic use
- Oocytes -- drug effects
- Radioligand Assay
- Rats
- Rats, Sprague-Dawley
- Receptors, Nicotinic -- drug effects
- Self Administration
- Smoking -- drug therapy
- Smoking Cessation
- Substance Withdrawal Syndrome
- Transfection
- Xenopus laevis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.